• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺嘌呤诱导的慢性肾脏病小鼠模型中连续两周的阿片类药物治疗会加重骨炎症状态并增加破骨细胞。

Two Weeks of Continuous Opioid Treatment in an Adenine-Induced Mouse Model of Chronic Kidney Disease Exacerbates the Bone Inflammatory State and Increases Osteoclasts.

机构信息

Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, 635 Barnhill Drive, MS 5045, Indianapolis, IN, 46202, USA.

Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.

出版信息

Calcif Tissue Int. 2024 Aug;115(2):174-184. doi: 10.1007/s00223-024-01239-8. Epub 2024 Jun 10.

DOI:10.1007/s00223-024-01239-8
PMID:38856730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11246326/
Abstract

Patients with chronic kidney disease (CKD) report high pain levels, but reduced renal clearance eliminates many analgesic options; therefore, 30-50% of CKD patients have chronic opioid prescriptions. Opioid use in CKD is associated with higher fracture rates. Opioids may directly alter bone turnover directly through effects on bone cells and indirectly via increasing inflammation. We hypothesized that continuous opioid exposure would exacerbate the high bone turnover state of CKD and be associated with elevated measures of inflammation. Male C57Bl/6J mice after 8 weeks of adenine-induced CKD (AD) and non-AD controls (CON) had 14-day osmotic pumps (0.25-µL/hr release) containing either saline or 50-mg/mL oxycodone (OXY) surgically implanted in the subscapular region. After 2 weeks, all AD mice had elevated blood urea nitrogen, parathyroid hormone, and serum markers of bone turnover compared to controls with no effect of OXY. Immunohistochemical staining of the distal femur showed increased numbers of osteocytes positive for the mu opioid and for toll-like receptor 4 (TLR4) due to OXY. Osteocyte protein expression of tumor necrosis factor-α (TNF-α) and RANKL were higher due to both AD and OXY so that AD + OXY mice had the highest values. Trabecular osteoclast-covered surfaces were also significantly higher due to both AD and OXY, resulting in AD + OXY mice having 4.5-fold higher osteoclast-covered surfaces than untreated CON. These data demonstrate that opioids are associated with a pro-inflammatory state in osteocytes which increases the pro-resorptive state of CKD.

摘要

患有慢性肾病(CKD)的患者报告疼痛水平较高,但肾脏清除率降低会消除许多镇痛选择;因此,30-50%的 CKD 患者有慢性阿片类药物处方。CKD 患者使用阿片类药物与更高的骨折率有关。阿片类药物可能通过直接作用于骨细胞或间接增加炎症来直接改变骨转换。我们假设持续的阿片类药物暴露会加剧 CKD 的高骨转换状态,并与炎症标志物的升高相关。8 周腺嘌呤诱导的 CKD(AD)和非 AD 对照组(CON)雄性 C57Bl/6J 小鼠接受手术植入肩胛下区的 14 天渗透泵(0.25-µL/hr 释放),内含盐水或 50-mg/mL 羟考酮(OXY)。2 周后,所有 AD 小鼠的血尿素氮、甲状旁腺激素和血清骨转换标志物均高于对照组,而 OXY 无影响。对远端股骨的免疫组织化学染色显示,由于 OXY,骨细胞中 mu 阿片受体和 toll 样受体 4(TLR4)阳性的骨细胞数量增加。由于 AD 和 OXY,骨细胞中肿瘤坏死因子-α(TNF-α)和 RANKL 的蛋白表达增加,因此 AD+OXY 小鼠的表达水平最高。由于 AD 和 OXY,破骨细胞覆盖的小梁表面也显著增加,导致 AD+OXY 小鼠的破骨细胞覆盖表面是未处理的 CON 的 4.5 倍。这些数据表明,阿片类药物与骨细胞中的促炎状态相关,从而增加了 CKD 的促吸收状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/900f8bd7366f/223_2024_1239_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/11d6cc01bb8f/223_2024_1239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/ef9b3c81ecd2/223_2024_1239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/9200e71e208a/223_2024_1239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/289e9347b493/223_2024_1239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/900f8bd7366f/223_2024_1239_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/11d6cc01bb8f/223_2024_1239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/ef9b3c81ecd2/223_2024_1239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/9200e71e208a/223_2024_1239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/289e9347b493/223_2024_1239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a3f/11246326/900f8bd7366f/223_2024_1239_Fig5_HTML.jpg

相似文献

1
Two Weeks of Continuous Opioid Treatment in an Adenine-Induced Mouse Model of Chronic Kidney Disease Exacerbates the Bone Inflammatory State and Increases Osteoclasts.腺嘌呤诱导的慢性肾脏病小鼠模型中连续两周的阿片类药物治疗会加重骨炎症状态并增加破骨细胞。
Calcif Tissue Int. 2024 Aug;115(2):174-184. doi: 10.1007/s00223-024-01239-8. Epub 2024 Jun 10.
2
Prolonged secondary hyperparathyroidism in adenine-induced CKD leads to skeletal changes consistent with skeletal hyporesponsiveness to PTH.腺嘌呤诱导的慢性肾脏病中,长期继发性甲状旁腺功能亢进会导致骨骼变化,与骨骼对甲状旁腺激素反应低下一致。
PLoS One. 2025 May 23;20(5):e0324628. doi: 10.1371/journal.pone.0324628. eCollection 2025.
3
Oxycodone for cancer-related pain.羟考酮治疗癌性疼痛。
Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD003870. doi: 10.1002/14651858.CD003870.pub7.
4
Opioids for cancer pain - an overview of Cochrane reviews.用于癌症疼痛的阿片类药物——Cochrane系统评价综述
Cochrane Database Syst Rev. 2017 Jul 6;7(7):CD012592. doi: 10.1002/14651858.CD012592.pub2.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Hydromorphone for cancer pain.氢吗啡酮用于癌症疼痛。
Cochrane Database Syst Rev. 2016 Oct 11;10(10):CD011108. doi: 10.1002/14651858.CD011108.pub2.
7
Oxycodone for cancer-related pain.羟考酮用于癌症相关疼痛。
Cochrane Database Syst Rev. 2017 Aug 22;8(8):CD003870. doi: 10.1002/14651858.CD003870.pub6.
8
Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD).雷洛昔芬联合机械加载改善慢性肾脏病(CKD)小鼠模型的骨组成和力学性能。
Bone. 2024 Jun;183:117089. doi: 10.1016/j.bone.2024.117089. Epub 2024 Apr 3.
9
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.用于癌症患者和接受姑息治疗患者的阿片类药物引起的肠道功能障碍的μ-阿片受体拮抗剂。
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
10
Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.吗啡、芬太尼、羟考酮或可待因用于治疗癌痛时对患者意识、食欲和口渴的影响。
Cochrane Database Syst Rev. 2014 May 29;2014(5):CD011056. doi: 10.1002/14651858.CD011056.pub2.

本文引用的文献

1
Sustained Morphine Delivery Suppresses Bone Formation and Alters Metabolic and Circulating miRNA Profiles in Male C57BL/6J Mice.持续吗啡给药抑制雄性 C57BL/6J 小鼠的骨形成并改变代谢和循环 miRNA 谱。
J Bone Miner Res. 2022 Nov;37(11):2226-2243. doi: 10.1002/jbmr.4690. Epub 2022 Sep 26.
2
Opioid Use in the Nondialysis Chronic Kidney Disease Population.非透析慢性肾脏病患者中的阿片类药物使用情况
Semin Nephrol. 2021 Jan;41(1):33-41. doi: 10.1016/j.semnephrol.2021.02.004.
3
Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL/6 mice with more severe deficits in cortical bone properties of male mice.
腺嘌呤诱导的慢性肾脏病在雄性和雌性 C57BL/6 小鼠中诱导出相似的骨骼表型,雄性小鼠的皮质骨特性缺陷更为严重。
PLoS One. 2021 Apr 23;16(4):e0250438. doi: 10.1371/journal.pone.0250438. eCollection 2021.
4
Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels.腺嘌呤诱导的慢性肾脏病引起的骨骼反应的特异性改变与甲状旁腺激素水平的差异有关。
Bone. 2021 Jul;148:115963. doi: 10.1016/j.bone.2021.115963. Epub 2021 Apr 17.
5
Factors Associated with Low Bone Density in Opioid Substitution Therapy Patients: A Systematic Review.阿片类药物替代疗法患者低骨密度的相关因素:一项系统评价
Int J Med Sci. 2021 Jan 1;18(2):575-581. doi: 10.7150/ijms.52201. eCollection 2021.
6
Assessment of Prescription Analgesic Use in Older Adults With and Without Chronic Kidney Disease and Outcomes.评估慢性肾脏病患者和非慢性肾脏病患者老年人群中处方镇痛药的使用情况和结局。
JAMA Netw Open. 2020 Sep 1;3(9):e2016839. doi: 10.1001/jamanetworkopen.2020.16839.
7
Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists.慢性肾脏病和血液透析患者阿片类药物的安全使用:非疼痛专科医生的实用技巧
Ther Clin Risk Manag. 2020 Sep 9;16:821-837. doi: 10.2147/TCRM.S262843. eCollection 2020.
8
Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility.Toll 样受体 4(TLR4)/阿片受体通路串扰及其对阿片类药物镇痛、免疫功能和胃肠道动力的影响。
Front Immunol. 2020 Jul 8;11:1455. doi: 10.3389/fimmu.2020.01455. eCollection 2020.
9
Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids.接受血液透析的患者中开具阿片类药物和加巴喷丁类药物处方的髋部骨折风险。
J Am Soc Nephrol. 2020 Jun;31(6):1325-1334. doi: 10.1681/ASN.2019090904. Epub 2020 May 5.
10
An updated analysis of opioids increasing the risk of fractures.阿普替林与丙咪嗪治疗抑郁症的疗效及安全性比较:一项随机对照试验的系统评价和 Meta 分析
PLoS One. 2020 Apr 9;15(4):e0220216. doi: 10.1371/journal.pone.0220216. eCollection 2020.